FDA Commissioner David Kessler, M.D., is leaving after six years at the agency
All News
Advertisement
Pharmaceutical Representative recently asked industry experts to predict the future. The following are their responses about the coming year.
Advertisement
Psychiatrists have developed new clinical guidelines for treating bipolar disorder and schizophrenia.
We asked top intellectual property lawyers about what the Supreme Courts decision will mean for pharma and biotech companies. Here is our forward-looking analysis of their comments.
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
